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Ubiquitination hasmany important cellular functions, including regulation of plasmamembrane endocytosis.
In their recent article in Cell, Patel et al. (2009) show that the activity of the multifunctional Salmonella
virulence protein SopB is controlled by ubiquitin-dependent delivery from the plasma membrane to the
Salmonella-containing vacuole.Many eukaryotic proteins are modified
posttranslationally by the addition of the
76 amino acid ubiquitinmolecule on lysine
residues. This process is controlled by
a cascade of enzymes and ends with the
action of E3 ligases, which control
substrate specificity. Ubiquitination regu-
lates many essential cellular processes,
including protein degradation by the
proteasome and endocytosis from the
plasma membrane. Several viral and
bacterial pathogens interfere with steps
in the ubiquitin pathway to alter cell
metabolism and apoptosis and to
evade immune responses. For example,
members of the herpesvirus family
encode ubiquitin E3 ligases that remove
cell surface receptors to evade immune
system recognition of virally infected cells
(Thomas et al., 2008).
A well-studied bacterium that interferes
with ubiquitin pathways is Salmonella
enterica serovar Typhimurium, which
causes gastrointestinal diseases in hu-
mans and a typhoid-like systemic infec-
tion in mice. Among its many virulence
determinants are two intensively studied
type III secretion systems (T3SS). They
are assembled independently at specific
stages of the infectious process. The
SPI-1 T3SS is activated in the gut lumen
and delivers several effector proteins
across the plasma membrane of epithelial
cells. These act together to induce bacte-
rial invasion and contribute to the early
maturation of the Salmonella-containing
vacuole (SCV). The SPI-2 T3SS is acti-
vated intracellularly and delivers a second
set of effector proteins across the vacu-
olar membrane. These further modify the
SCV and enable intracellular bacterial
replication. Several SPI-1 and SPI-2
effectors are known to interfere with
ubiquitin-related processes directly. Forexample, SopA (SPI-1-associated) and
SspH2 (SPI-2-associated) are E3 ligases;
SseL is a SPI-2 T3SS deubiquitinase;
and SopA, SopE, SptP and SopB/SigD
(hereafter referred to as SopB) are all
SPI-1 T3SS effectors that become ubiqui-
tinated following their translocation.
The phosphoinositide phosphatase
activity of SopB was discovered over
10 years ago. Since then it has been
shown to control a broad range of physio-
logical processes, all of which require its
phosphatase activity. Initial work demon-
strated that SopB is required for fluid
secretion and neutrophil accumulation in
the intestine (Layton and Galyov, 2007).
It activates an exchange factor for
RhoG, through which it remodels actin to
cause membrane ruffles that are charac-
teristic of the invasion process. Then,
by eliminating phosphatidylinositol-4,5-
bisphosphate in the invaginating regions
of the ruffles, SopB promotes membrane
fission and efficient formation of the
nascent vacuole (Terebiznik et al., 2002).
While at the plasma membrane, SopB
also activates the proto-oncogene
product Akt, which might promote epithe-
lial cell survival (Layton andGalyov, 2007).
Remarkably, SopB’s work doesn’t stop
there. The protein persists for several
hours on the SCV, where it interferes
with vacuole biogenesis through its phos-
phatidylinositol-3,5-bisphosphate phos-
phatase activity. This results in the
maintenance of high levels of phosphati-
dylinositol-3-phosphate [PI(3)P] in the
SCV membrane (Hernandez et al., 2004),
which in turnmight interfere with the vacu-
olar maturation pathway that normally
culminates in the formation of a phagoly-
sosome (Layton and Galyov, 2007).
How SopB interferes with these diverse
cellular pathways was not known. In aCell Host & Microrecent issue ofCell, Gala´n and colleagues
show that ubiquitinated SopB forms are
stable within the cell and that their pres-
ence is not affected by the deletion of
Salmonella E3 ligase genes. SopB can
be ubiquitinated on any of nine lysine resi-
dues in its N-terminal region. Through the
use of ubiquitin mutants lacking internal
lysine residues, Patel et al. (2009) demon-
strate that SopB is multi monoubiquiti-
nated. A SopB mutant that cannot be
ubiquitinated (SopBDub) is used in subse-
quent experiments to determine the
importance of these modifications to the
localization and function of SopB during
Salmonella infection. A key finding is that
bacterially delivered SopBDub remains at
the plasma membrane. Therefore, ubiqui-
tination of SopB is necessary for its inter-
nalization and targeting to the SCV. An
elegant mixed infection experiment
reveals that SopB injected by noninvasive
bacteria is delivered to vacuoles enclos-
ing invasive bacteria. This suggests that
transfer of the ubiquitinated form to the
SCV does not necessarily occur passively
during formation of the vacuole, but
involves an active pathway. Like tyrosine
kinase growth-factor receptors, the
inability to internalise SopBDub leads to
sustained activation of its targets at the
plasma membrane.
The SopBDub mutant does not affect
internalisation of Salmonella, but its
absence from the SCV results in an intra-
cellular replication defect, similar to that
seen in the DsopB strain. This indicates
that the replication defect is not due to
the activity of SopB at the plasma
membrane but to its phosphoinositide re-
modelling at the SCV. Recent work has
shown that SopB does not generate
PI(3)P by direct dephosphorylation
of other phosphoinositides, but viabe 5, April 23, 2009 ª2009 Elsevier Inc. 309
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effector Vps34 to the SCV (Mallo
et al., 2008). Consistent with this
finding, Patel et al. (2009) show
that SopBDub is unable to recruit
Rab5 to the SCV. Importantly,
the work enables dissection of
the relative importance of SopB
activitiesduringSalmonella infec-
tion. At the plasma membrane,
SopB’s role in stimulating bacte-
rial internalization and actin re-
modeling is partially redundant
with the SPI-1 effectors SopE
and SopE2 (Hernandez et al.,
2004). However, SopB’s nonre-
dundant role in remodeling phos-
phoinositides at the SCV is
entirely dependent on its delivery
to that compartment by the ubiq-
uitin machinery.
An obvious question that arises
from these studies concerns the
fate of vacuoles enclosingDsopB
or SopBDub mutant bacteria and
the cause of the intracellular
growth defect (Figure 1). As
PI(3)P has an important role in
regulating late endosome biogenesis,
loss of SopB could result in the SCV
following the default phagosome matura-
tion pathway leading to the formation of
phagolysosomes (Hernandez et al., 2004;
Layton and Galyov, 2007), but this has
yet to be shown directly. Several other
questions are raised by this work
(Figure 1). What is the E3 ligase that ubiq-
uitinates SopB, andwhichmachinery is re-
cruited to allow internalization? Patel et al.
(2009) demonstrate that the known E3
ligases encoded by Salmonella are not
involved, but this does not preclude the
presence of other, unidentified Salmonella
E3 ligases that could act on SopB.
Convergent evolution has allowed bacte-
rial effectors to target their activities to
cellular pathways, but these proteins
frequently have little or no similarity to their
eukaryotic counterparts. This is exempli-
fied by the recent solution of the structure
of the Salmonella E3 ligase SspH2, which
possesses a novel catalytic domain,
different from those found in eukaryotic
E3 ligases (Quezada et al., 2009). Several
mammalian cell surface receptors depend
on ubiquitin for their internalization, and
they suggest the presence of other E3
ligases that could be involved in modifica-
tion of SopB: among these are the Cbl and
Nedd4 families, whose members are also
involved in regulating growth factor recep-
tors; and the MARCH family (related to
several viral E3 ligases), which regulate
immune receptors at the cell surface.
With regard to the identity of the cellular
machinery required for SopB internaliza-
tion, Patel et al. (2009) show that interfer-
ence with dynamin, clathrin, epsin, or
members of the ESCRT complex do not
affect SopB localization. An alternative
pathway for internalization has been
documented for the transforming growth
factor-b (TGF-b) receptor and the
epidermal growth factor receptor (EGFR).
The TGF-b receptor can associate with
the Smad7-Smurf2 E3 ubiquitin ligase
(Kavsak et al., 2000) and localize to caveo-
lae before internalization. A monoubiquiti-
nated EGFR was internalized in a clathrin-
independent manner (Sigismund et al.,
2005). Three proteins with ubiquitin
binding domains—Eps15, Eps15R, and
epsin—which normally localize to cla-
thrin-coated pits, were required for cla-
thrin-independent EGFR internalization.
These studies indicate a potential role for
caveolae in SopB internalization, as well
as the possibility of redundancy between
the adaptors epsin, Eps15 and Eps15R.
It seems unlikely that the mechanism of
SopB internalization will be
unique to the bacterial protein
and that it will instead have
usurped an existing cellular
pathway.
Gala´n’s group has previously
shown that the ubiquitin-protea-
some system is manipulated by
the Salmonella effectors SopE
andSptP. These effector proteins
undergo different rates of
degradation, allowing temporal
regulation of their opposing func-
tions on Rho-family GTPases
(Kubori andGalan, 2003). Ubiqui-
tin modification of SopB pro-
vides spatiotemporal regulation
and diversification of function
through relocation. This finding
has echoes of the exquisite
ubiquitin-mediated regulation of
the mammalian MAP kinase
pathway. An example of this
regulation is the formation of
lysine 63 polyubiquitin chains
on TRAF2, resulting not in its
degradation, but rather in its
altered localization into a new
subcellular compartment, enabling selec-
tive activation of the MAPK JNK (c-Jun
N-terminal kinase) (Habelhah et al., 2004).
In conclusion, the important conceptual
advance to emerge from the work of Patel
et al. (2009) is that ubiquitin-dependent
effector redistribution provides a means
for extending and diversifying the biolog-
ical function of the effector. The use of
ubiquitin-dependent machinery by SopB
to obtain a ‘‘ticket to ride’’ into the cell
illustrates the extent to which bacteria can
manipulate cellular pathways. Bacterial
effectors are known to mimic eukaryotic
proteins as a result of convergent evolu-
tion; this work provides another example
of their extraordinary sophistication.
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Figure 1. SopB Localization: Ubiquitination Provides
Answers and Poses New Questions
Salmonella invades epithelial cells through the action of effector
proteins translocated by a type III secretion system. These effectors
stimulate actin remodeling and membrane ruffling, partially through
the activity of SopB at the plasma membrane. SopB is ubiquitinated
(Ub) by unknown E3 ligase(s) (A). This modification might aid recruit-
ment of SopB to the invaginating membrane and is essential for its
delivery to the Salmonella-containing vacuole (SCV) by unidentified
machinery (B). At the SCV, SopB contributes to bacterial replication
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We live on a moldy planet—it is estimated
that there are well over one million species
of fungi.Thechallengeofdefendingagainst
fungal invasion is formidable given the
frequent exposure to environmental fungi.
Strong innate and adaptive host defenses
exist toprotect animals against fungal inva-
sion, and therefore in persons with healthy
immune systems, serious fungal diseases
are rare. However, with the increasing
numbers of immunocompromised individ-
uals, the incidence of life-threatening
fungal infections has reached epidemic
proportions.
Fungi and animals are members of the
eukaryotic kingdom and on a cellular level
have more similarities than differences.
The major difference, which is exploited
by the innate immune system, is the pres-
ence of cell walls on fungi. While there is
much interspecies and even intraspecies
variability in fungal cell wall composition,
cell walls of virtually all medically impor-
tant fungi have significant amounts of
three polysaccharides: b-glucan, chitin,
and mannan (Netea et al., 2008). b-(1,3)-
glucans containing covalent links to
b-(1,6)-glucan and chitin form the core
structural component. Mannoproteins
are attached to this skeleton. Both
mammalian and fungal cells glycosylate
proteins via N- and O-linkages. However,
whereas mammalian proteins rarely haveQuezada, C.M., Hicks, S.W., Galan, J.E., and Steb-
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otal role in defenses against Candid
e fungal cell wall and their cognate rec
ible for IL-17 production and find a p
exposed mannose residues, fungi utilize
mannose as their preferred sugar (Levitz
and Specht, 2006). These highly manno-
sylated polysaccharides are referred to
asmannans, and in thecellwall ofCandida
albicans, chains comprised of up to 200
mannose groups can be found (Levitz
and Specht, 2006; Netea et al., 2008).
Importantly, mannans tend to be on the
outer fungal cell wall whereas b-glucans
are largely on the inside. However, some
surface exposure of b-glucans does take
place, particularly in areas where yeast
cells bud.
Immunerecognitionof the fungalcellwall
is largely achieved by pattern-recognition
receptorsonphagocytes, includingneutro-
phils, monocytes, macrophages, and
dendritic cells (DC) (Netea et al., 2008).
Mannans are sensed most notably by the
mannose receptor (CD206) and DC-SIGN
(CD209). Numerous receptors have been
described that recognize b-glucans, and
while their relative importance has not
been firmly established, dectin-1 appears
to play a predominant role. Toll-like recep-
tors (TLR)2 and4alsoare involved in fungal
recognition, although most fungal ligands
for TLRshavenotbeendefinedonamolec-
ular level. Opsonization of fungi with
complement and antibody results in recog-
nition by complement and Fc receptors,
respectively, on host cells. Thus, a myriad
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A CD4+ T cell response is critical for the
control ofmany fungal infections, including
mucocutaneous candidiasis. Different
subsetsofCD4+Tcells develop fromnaive
T cells under the influence of polarizing
signals and master transcription factors
(Acosta-Rodriguezetal., 2007). Inhumans,
naive T cells are thought to become
committed to the Th17 lineage (so named
because theysecrete IL-17)whenexposed
to the cytokines TGF-b, IL-1b, and IL-6,
IL-21, or IL-23 (Manel et al., 2008). Induc-
tion of the transcription factor, RORgt, is
also necessary. Terminal differentiation
and population expansion requires IL-23
(McGeachy et al., 2009). Accumulating
evidence points to Th17 cells as key
effector cells in the response to fungal
infections, including C. albicans (Acosta-
Rodriguez et al., 2007; Conti et al., 2009;
LeibundGut-Landmannetal., 2007).More-
over, while studieswith knockoutmice and
purified preparations of b-glucans have
implicated dectin-1 as being central to
the Th17 skewing seen in fungal infections,
contributions from other receptors have
not been excluded.
In this issue, van de Veerdonk and
colleagues provide further evidence for
a predominant role of Th17 cells in
mediating the CD4+ T cell response to
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